Adverum Biotechnologies, Inc. (ADVM)
4.36
+0.10
(+2.35%)
USD |
NASDAQ |
Dec 08, 16:00
Adverum Biotechnologies Market Cap: 96.26M for Dec. 8, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 888.45B |
| Pfizer Inc. | 145.27B |
| Recursion Pharmaceuticals, Inc. | 2.540B |
| Quantum-Si, Inc. | 306.00M |
| X4 Pharmaceuticals, Inc. | 327.89M |
Market Cap Related Metrics
| PEG Ratio | -0.0241 |
| Price | 4.36 |
| Earnings Yield | -196.7% |
| PEGY Ratio | -0.0241 |